Full IPO calendar & reports HERE. The follow list is in order of largest IPO first.
(1) Based in Luxembourg, Orion Engineered Carbons S.a r.l. (OEC) scheduled a $315 million IPO on the NYSE with a market capitalization of $1.3 billion at a price range midpoint of $22.50 for Friday, July 25, 2014.
OEC is a leading global producer of carbon black. Carbon black is a form of carbon used to improve certain properties of materials into which it is added.
(2) Based in Hilliard, OH, Advanced Drainage Systems (WMS) scheduled a $261 million IPO on the NYSE with a market capitalization of $950 million at a price range midpoint of $18 for Friday, July 25, 2014.
WMS is the leading manufacturer of high performance thermoplastic corrugated pipe, providing a comprehensive suite of water management products and superior drainage solutions for use in the construction and infrastructure marketplace.
(3) Based in Greenwich, CT, Townsquare Media, LLC (TSQ) scheduled a $125 million IPO on the NYSE with a market capitalization of $252 million at a price range midpoint of $15 for Thursday, July 24, 2014.
TSQ is an integrated and diversified media and entertainment company that owns and operates market leading radio stations, digital and social properties and live events in small and mid-sized markets across the United States, delivering national scale and expertise to the communities it serves on a local level.
(4) Based in Costa Mesa, CA, El Pollo Loco Holdings (LOCO) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $502 million at a price range midpoint of $14 for Friday, July 25, 2014.
El Pollo Loco is a differentiated restaurant concept that specializes in fire-grilling citrus-marinated chicken in front of its customers. LOCO has both company-owned and franchised stores
(5) Based in Athlone, Ireland, Innocoll GmbH (INNL) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $149 million at a price range midpoint of $14 for Friday, July 25, 2014.
INNL is a global, commercial stage, specialty pharmaceutical company, with late stage development programs targeting areas of significant unmet medical need.
(6) Based in Brisbane, CA, Atara Biotherapeutics (ATRA) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $291 million at a price range midpoint of $15 for Thursday, July 24, 2014.
ATRA is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology.
(7) Based in Bedford, MA, Ocular Therapeutix (OCUL) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $309 million at a price range midpoint of $15 for Friday, July 25, 2014.
OCUL is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology.
(8) Based in Seattle, WA,Immune Design (IMDZ) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $202 million at a price range midpoint of $13 for Thursday, July 24, 2014.
IMDZ is a clinical stage immuno-therapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease.
(9) Based in Menlo Park, CA,Intersect ENT (XENT) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $270 million at a price range midpoint of $12 for Thursday, July 24, 2014.
XENT is a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions.
(10) Based in Houston, TX,Spark Energy (SPKE) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $275 million at a price range midpoint of $20 for Thursday, July 24, 2014.
SPKE is an independent retail energy services company founded in 1999 that provides residential and commercial customers in competitive markets across the United States with an alternative choice for their natural gas and electricity.
(11) Based in Ness Ziona, Israel,Mapi – Pharma Ltd. (MAPI) scheduled a $38 million IPO on the Nasdaq with a market capitalization of $213 million at a price range midpoint of $14 for Thursday, July 24, 2014.
MAPI is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value generic drugs that include complex APIs, formulations and LCM products that target large markets.
Read Next
